Alireza Najafian1, Stacie Kahan1, Matthew T Olson2, Ralph P Tufano3, Martha A Zeiger4. 1. Endocrine Surgery, Department of Surgery, The Johns Hopkins University School of Medicine, 600 N. Wolfe St Blalock 606, Baltimore, MD, 21287, USA. 2. Division of Cytopathology, Department of Pathology, The Johns Hopkins University School of Medicine, Baltimore, MD, 21287, USA. 3. Division of Head and Neck Endocrine Surgery, Department of Otolaryngology-Head and Neck Surgery, The Johns Hopkins University School of Medicine, Baltimore, MD, 21287, USA. 4. Endocrine Surgery, Department of Surgery, The Johns Hopkins University School of Medicine, 600 N. Wolfe St Blalock 606, Baltimore, MD, 21287, USA. mzeiger@jhmi.edu.
Abstract
BACKGROUND: Intraoperative PTH (IOPTH) monitoring has been widely used to confirm the removal of the culprit lesion during operation. However, the true benefit of IOPTH in patients with preoperatively well-localized single adenoma has been questioned. The aim of this study was to examine how or if IOPTH changes the surgical management and outcomes in patients with only one positive or only indeterminate localization studies. METHODS: This is a retrospective review of data from a parathyroid surgery database and patient records from July 2004 to June 2014, including patients with primary hyperparathyroidism with a planned MIP by two experienced endocrine surgeons after ≥1 positive/indeterminate preoperative localization study by ultrasound and/or sestamibi. RESULTS: A total of 482 patients with positive (342: 259 only 1, 83 with ≥2) or indeterminate (140: 105 only 1, 35 with ≥2) preoperative imaging studies were included. IOPTH changed the management in only 16 (3%) patients, with an additional lesion found in 12 of them. Surgical cure was achieved in 471 (98%) of patients (98% in the positive vs. 97% in the indeterminate group, p 0.58). With or without IOPTH, the cure rate would not have been significantly different in patients with only 1 positive preoperative imaging (96 vs. 98%, p 0.12). Similar results were seen in those with ≥2 indeterminate (100% cure rate with or without IOPTH). CONCLUSION: Our study suggests that MIP may be safely and successfully performed without IOPTH for patients with ≥1 positive or ≥2 indeterminate preoperative imaging studies. This study is retrospective within inherent biases, and future prospective study is warranted.
BACKGROUND: Intraoperative PTH (IOPTH) monitoring has been widely used to confirm the removal of the culprit lesion during operation. However, the true benefit of IOPTH in patients with preoperatively well-localized single adenoma has been questioned. The aim of this study was to examine how or if IOPTH changes the surgical management and outcomes in patients with only one positive or only indeterminate localization studies. METHODS: This is a retrospective review of data from a parathyroid surgery database and patient records from July 2004 to June 2014, including patients with primary hyperparathyroidism with a planned MIP by two experienced endocrine surgeons after ≥1 positive/indeterminate preoperative localization study by ultrasound and/or sestamibi. RESULTS: A total of 482 patients with positive (342: 259 only 1, 83 with ≥2) or indeterminate (140: 105 only 1, 35 with ≥2) preoperative imaging studies were included. IOPTH changed the management in only 16 (3%) patients, with an additional lesion found in 12 of them. Surgical cure was achieved in 471 (98%) of patients (98% in the positive vs. 97% in the indeterminate group, p 0.58). With or without IOPTH, the cure rate would not have been significantly different in patients with only 1 positive preoperative imaging (96 vs. 98%, p 0.12). Similar results were seen in those with ≥2 indeterminate (100% cure rate with or without IOPTH). CONCLUSION: Our study suggests that MIP may be safely and successfully performed without IOPTH for patients with ≥1 positive or ≥2 indeterminate preoperative imaging studies. This study is retrospective within inherent biases, and future prospective study is warranted.
Authors: Vladimir K Neychev; Guennadi Kouniavsky; Zita Shiue; Don N Udall; Helina Somervell; Christopher B Umbricht; Martha A Zeiger Journal: World J Surg Date: 2011-01 Impact factor: 3.352
Authors: Vladimir K Neychev; Maher Ghanem; Stuart L Blackwood; Patricia Aragon Han; Roghayeh Fazeli; Eric Schneider; Alireza Najafian; Dov C Bloch; Michael C Bard; Jay H Klarsfeld; Martha A Zeiger; Richard J Lipton Journal: Int J Surg Date: 2015-11-19 Impact factor: 6.071
Authors: Nicholas Smith; Jeffrey Scott Magnuson; David Macy Vidrine; Brian Kulbersh; Glenn E Peters Journal: Arch Otolaryngol Head Neck Surg Date: 2009-11
Authors: Faisal Zawawi; Alex M Mlynarek; Arielle Cantor; Rickul Varshney; Martin J Black; Michael P Hier; Louise Rochon; Richard J Payne Journal: J Otolaryngol Head Neck Surg Date: 2013-12-19